Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that men with frontal fibrosing alopecia were more likely to have facial papules, androgenetic alopecia, and body hair loss compared to women, with the average patient age being higher than in other series, potentially explaining these differences.

This article discusses three controversial hair growth disorders but reports no new research findings; it explores alopecia areata incognita, pseudopelade of Brocq, and psoriasis-linked alopecia.

This review discusses cultural hair care practices for African American scalp health and recommends combining clinical evaluation with cultural knowledge, but reports no new research findings.

The document suggests a possible link between mast cells and scarring alopecia, recommending more research for potential treatments.

This study explored the potential use of natural ingredients in managing alopecia areata, investigating their safety and efficacy as alternatives to conventional chemical treatments.

This article discusses the challenges in treating androgenic alopecia and highlights its potential links to coronary heart disease and metabolic syndrome but reports no new clinical findings.

This study concluded that 5% topical Minoxidil remains a first-line treatment for female androgenetic alopecia by increasing hair density and thickness, while low-dose oral Minoxidil and combination therapies may also be effective.

This chapter provides a comprehensive review of androgenetic alopecia, covering its key physiological mechanisms, diagnostic methods, and a variety of treatment options ranging from topical therapies to aesthetic and regenerative procedures, emphasizing recent advances observed in dermatological practice.

This study conducted a narrative literature review on androgenetic alopecia, highlighting the clinical diagnosis and management strategies, including minoxidil and 5-alpha-reductase inhibitors for men, and antiandrogens for women, along with the use of aesthetic procedures like microneedling as complementary therapies.

This review highlights the diverse cutaneous manifestations in immunocompromised patients, emphasizing the importance of early recognition for improved patient prognosis.

This review found a significant immunological link between diffuse alopecia areata and autoimmune thyroid disorders, particularly Hashimoto's thyroiditis, highlighting the importance of early recognition and thyroid function evaluation to improve clinical management and avoid diagnostic delays.

This integrative literature review revealed that chronic stress, characterized by elevated cortisol levels, negatively impacts hair follicle integrity and contributes to alopecia by promoting the premature transition from the growth phase to the resting phase of the hair cycle.

This study reviewed interventions for post-COVID-19 alopecia and concluded that integrated physiotherapeutic strategies, including photobiomodulation, micro-needling, electrotherapy, and scalp massage, can reduce hair loss and improve hair density, contributing positively to patient quality of life.

The abstract discusses the multidisciplinary nature and advancement of dermatology and aesthetic procedures within the health sciences, emphasizing the integration of diagnostic, corrective, preventive, and therapeutic approaches, but does not provide specific study results.

This abstract discusses the broad scope of dermatology and aesthetic procedures, highlighting their significant multidisciplinary evolution within the health sciences, but it does not report specific study results.

This integrative literature review found that hydroxychloroquine may stabilize inflammatory scarring autoimmune alopecias like frontal fibrosing alopecia, especially when combined with other therapies, while its effectiveness in non-scarring alopecias appears inconsistent and is limited to refractory cases.

This source provides a comprehensive reference on recent advancements and innovative approaches in the diagnosis and treatment of common dermatological conditions, highlighting significant updates for clinical practice in dermatology.

In this study, a literature review concluded that minoxidil is safe and effective for treating androgenetic alopecia, with few side effects, and highlighted the role of pharmacists in optimizing treatment by monitoring use and fostering adherence.

Pharmacists play a crucial role in improving treatment outcomes and staying updated on various health conditions.

This article explores the evolution of scalp therapy in barbershops from a trend into a responsible practice, emphasizing the importance of clinical consistency and proposing a framework focused on client safety, documentation, and appropriate referrals to dermatology.

This study reviewed the etiology, mechanisms, and treatments of scarring alopecias and noted that early and accurate identification is crucial due to overlapping features among different types, making differential diagnosis challenging.

This study reviewed the use of microinfusion of microparticles (MMP®) with methotrexate for treating alopecia frontal fibrosante and found it reduced symptoms associated with the condition and improved specific scalp measurements, showing that the technique is safe and well-tolerated.

This study reviewed existing literature to provide comprehensive insights into diagnosing and managing alopecia areata, emphasizing the importance of understanding its classification, etiology, and the diverse treatment options available for improved patient care.

In this retrospective study, researchers found that baricitinib was effective for treating moderate to severe alopecia areata, with response rates in 24 patients comparable to existing real-world data, and no new safety concerns were identified.

In this case study, a patient with longstanding androgenetic alopecia and systemic lupus erythematosus showed a positive response to both oral and topical minoxidil after suboptimal outcomes from previous treatments, highlighting the importance of timely diagnosis and management to reduce psychiatric risk factors.

This study found that lupus discoid lesions on the scalp are more common in females and are associated with a higher incidence of other autoimmune diseases compared to lesions in other areas.

This study found that PRP treatment showed better results than injectable minoxidil for reducing hair loss and promoting hair growth, with noticeable effects after the second application.

This bibliographic review highlights the importance of microneedling as a dermatological technique for treating androgenetic alopecia, emphasizing its potential benefits and the need for personalized treatment by skilled dermatologists.

In this study, a case of post-COVID telogen effluvium was reported in which fever and stress following COVID-19 triggered temporary hair loss, and topical treatment showed positive results in improving this condition.

This review found that various treatments like finasteride, minoxidil, and platelet-rich plasma, combined with supplements, showed positive responses in combating androgenetic alopecia. The study specifically highlighted finasteride's effectiveness in increasing hair growth, with different dosages yielding notable improvements in both men and pre-menopausal women.